Cargando…

A Novel Scoring Model of Deubiquitination Patterns Predicts Prognosis and Immunotherapeutic Response in Hepatocellular Carcinoma

Aberrant expression of deubiquitinases (DUBs) is significantly associated with tumorigenesis. However, the precise impact of deubiquitination on the tumour microenvironment (TME) and immunotherapy in hepatocellular carcinoma (HCC) remains unclear. In this study, we comprehensively characterized the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jiahao, Wu, Gefeng, Peng, Rui, Cao, Jun, Tu, Daoyuan, Zhou, Jie, Su, Bingbing, Jin, Shengjie, Jiang, Guoqing, Zhang, Chi, Bai, Dousheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518587/ https://www.ncbi.nlm.nih.gov/pubmed/37734237 http://dx.doi.org/10.1016/j.tranon.2023.101789

Ejemplares similares

Causal associations between gut microbiota and primary biliary cholangitis: a bidirectional two-sample Mendelian randomization study
por: Zhang, Jiahao, et al.
Publicado: (2023)

Screening and Verification of Key Ubiquitination Genes Related to Immune Infiltration in Stage III/IV Hepatocellular Carcinoma
por: Tang, Yuhong, et al.
Publicado: (2023)

Bioinformatics analysis of immune infiltrates and tripartite motif (TRIM) family genes in hepatocellular carcinoma
por: Cao, Jun, et al.
Publicado: (2022)

RNF173 suppresses RAF/MEK/ERK signaling to regulate invasion and metastasis via GRB2 ubiquitination in Hepatocellular Carcinoma
por: Zhou, Jie, et al.
Publicado: (2023)

GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma
por: Wang, Guifu, et al.
Publicado: (2020)

CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma
por: Jiang, Guoqing, et al.
Publicado: (2016)

Development of tryptophan metabolism patterns to predict prognosis and immunotherapeutic responses in hepatocellular carcinoma
por: Long, Guo, et al.
Publicado: (2023)

A prognostic model for hepatocellular carcinoma based on apoptosis-related genes
por: Liu, Renjie, et al.
Publicado: (2021)

Identification of a Novel Metastasis-Related miRNAs-Based Signature for Predicting the Prognosis of Hepatocellular Carcinoma
por: Chen, Yuan, et al.
Publicado: (2021)

Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein
por: Yuan, Tao, et al.
Publicado: (2019)

Implications of m6A-associated snRNAs in the prognosis and immunotherapeutic responses of hepatocellular carcinoma
por: Zhang, Cheng, et al.
Publicado: (2022)

Immunotherapeutic approaches for hepatocellular carcinoma
por: Longo, Vito, et al.
Publicado: (2017)

Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
por: Xu, Hao, et al.
Publicado: (2021)

CircRNAs in hepatocellular carcinoma: characteristic, functions and clinical significance
por: Zhou, Yujun, et al.
Publicado: (2022)

Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes
por: Xue, Chen, et al.
Publicado: (2022)

Immunotherapeutic Approaches for Treating Hepatocellular Carcinoma
por: Shen, Wanying, et al.
Publicado: (2022)

Predicting prognosis and immunotherapeutic response of clear cell renal cell carcinoma
por: Wang, Jun, et al.
Publicado: (2022)

Identification and validation in a novel quantification system of the glutamine metabolism patterns for the prediction of prognosis and therapy response in hepatocellular carcinoma
por: Jin, Shengjie, et al.
Publicado: (2022)

Expression Patterns of Necroptosis-Related Genes: Predicting Prognosis and Immunotherapeutic Effects in Cutaneous Melanoma
por: Dong, Dong, et al.
Publicado: (2022)

The Pyroptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immunotherapeutic Efficiency in Hepatocellular Carcinoma
por: Wang, Tao, et al.
Publicado: (2022)

Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes
por: Fang, Yi-Zheng, et al.
Publicado: (2023)

Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma
por: Su, Yuanshuai, et al.
Publicado: (2023)

A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes
por: Xiong, Chen, et al.
Publicado: (2020)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021)

Exploring immune-related signatures for predicting immunotherapeutic responsiveness, prognosis, and diagnosis of patients with colon cancer
por: Cao, Lichao, et al.
Publicado: (2022)

Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma
por: Koh, Benjamin, et al.
Publicado: (2023)

Deubiquitinating Enzymes and Bone Remodeling
por: Guo, Yu-chen, et al.
Publicado: (2018)

Cuproplasia characterization in colon cancer assists to predict prognosis and immunotherapeutic response
por: Zhang, Bomiao, et al.
Publicado: (2023)

USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c
por: Yao, Ye, et al.
Publicado: (2022)

Advances in deubiquitinating enzymes in lung adenocarcinoma
por: Zhou, Xi-Jia, et al.
Publicado: (2021)

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma
por: Chen, Hongquan, et al.
Publicado: (2022)

Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)
por: Cao, Rui, et al.
Publicado: (2020)

Prognostic related gene index for predicting survival and immunotherapeutic effect of hepatocellular carcinoma
por: Du, Zhongxiang, et al.
Publicado: (2023)

Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via CYLD-Mediated Deubiquitination
por: Qiu, Chengjiang, et al.
Publicado: (2020)

A plague of deubiquitination
por: Powell, Kendall
Publicado: (2005)

Deubiquitinating enzymes as oncotargets
por: McClurg, Urszula L., et al.
Publicado: (2015)

Deubiquitination in virus infection
por: Lindner, Holger A.
Publicado: (2007)

USP14 maintains HIF1-α stabilization via its deubiquitination activity in hepatocellular carcinoma
por: Lv, Chi, et al.
Publicado: (2021)

The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
por: Bertino, Gaetano, et al.
Publicado: (2015)

Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular Carcinoma
por: Devan, Aswathy R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6f22fl3114dp7jrour5at1gep3